Acenocoumarol

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

Jump to: navigation, search
220pxpx }}
Acenocoumarol
Systematic (IUPAC) name
2-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-4H-
chromen-4-one
Identifiers
CAS number 152-72-7
ATC code B01AA07
PubChem 9052
Chemical data
Formula C19H15NO6 
Mol. mass 353.326 g/mol
Pharmacokinetic data
Bioavailability  ?
Metabolism Hepatic
Half life 8 to 11 hours
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status

POM(UK)

Routes Oral

WikiDoc Resources for

Acenocoumarol

Articles

Most recent articles on Acenocoumarol

Most cited articles on Acenocoumarol

Review articles on Acenocoumarol

Articles on Acenocoumarol in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Acenocoumarol

Images of Acenocoumarol

Photos of Acenocoumarol

Podcasts & MP3s on Acenocoumarol

Videos on Acenocoumarol

Evidence Based Medicine

Cochrane Collaboration on Acenocoumarol

Bandolier on Acenocoumarol

TRIP on Acenocoumarol

Clinical Trials

Ongoing Trials on Acenocoumarol at Clinical Trials.gov

Trial results on Acenocoumarol

Clinical Trials on Acenocoumarol at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Acenocoumarol

NICE Guidance on Acenocoumarol

NHS PRODIGY Guidance

FDA on Acenocoumarol

CDC on Acenocoumarol

Books

Books on Acenocoumarol

News

Acenocoumarol in the news

Be alerted to news on Acenocoumarol

News trends on Acenocoumarol

Commentary

Blogs on Acenocoumarol

Definitions

Definitions of Acenocoumarol

Patient Resources / Community

Patient resources on Acenocoumarol

Discussion groups on Acenocoumarol

Patient Handouts on Acenocoumarol

Directions to Hospitals Treating Acenocoumarol

Risk calculators and risk factors for Acenocoumarol

Healthcare Provider Resources

Symptoms of Acenocoumarol

Causes & Risk Factors for Acenocoumarol

Diagnostic studies for Acenocoumarol

Treatment of Acenocoumarol

Continuing Medical Education (CME)

CME Programs on Acenocoumarol

International

Acenocoumarol en Espanol

Acenocoumarol en Francais

Businness

Acenocoumarol in the Marketplace

Patents on Acenocoumarol

Experimental / Informatics

List of terms related to Acenocoumarol

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884

Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Acenocoumarol is an anticoagulant that functions as a vitamin K antagonist (like warfarin).

It is a derivative of coumarin and is marketed under the brand names Sintrom and Sinthrome®.

External links

  • DDB 29202
  • Cesar J, García-Avello A, Navarro J, Herraez M (2004). "Aging and oral anticoagulant therapy using acenocoumarol.". Blood Coagul Fibrinolysis 15 (8): 673-6. PMID 15613922.
  • Lengyel M (2004). "Warfarin or acenocoumarol is better in the anticoagulant treatment of chronic atrial fibrillation?". Orv Hetil 145 (52): 2619-21. PMID 15724697.
  • Ufer M (2005). "Comparative pharmacokinetics of vitamin K antagonists: warfarin, phenprocoumon and acenocoumarol.". Clin Pharmacokinet 44 (12): 1227-46. PMID 16372822.
  • Montes R, Ruiz de Gaona E, Martínez-González M, Alberca I, Hermida J (2006). "The c.-1639G > A polymorphism of the VKORC1 gene is a major determinant of the response to acenocoumarol in anticoagulated patients.". Br J Haematol 133 (2): 183-7. PMID 16611310.


WikiDoc Help Menu

Quick Start..

Editing basics

Advanced editing

Communicating your edits

Help Videos You Can Watch


Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

de:Acenocumarol

Personal tools
In other languages